A study conducted in an animal model confirmed that a heterozygous PTEN mutation leads to the formation of endometrial cancer in as many as 30% of cases, but this effect may be exacerbated by adiponectin deficiency, due to activation of the mitogen-activated protein kinase (MAPK) pathway [74]. Here, PTEN is linked to endometrial cancer.